相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)
Emanuele Angelucci et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Deferasirox treatment for myelodysplastic syndromes: real-life efficacy and safety in a single-institution patient population
Massimo Breccia et al.
ANNALS OF HEMATOLOGY (2012)
Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion-Dependent Patients With Myelodysplastic Syndrome
Alan F. List et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
Uwe Platzbecker et al.
LEUKEMIA RESEARCH (2012)
Myelodysplastic Syndromes: Dissecting the Heterogeneity
Peter L. Greenberg
JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox
Florian Nolte et al.
LEUKEMIA RESEARCH (2011)
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
Norbert Gattermann et al.
LEUKEMIA RESEARCH (2010)
Deferasirox in MDS patients with transfusion-caused iron overload-a phase-II study
Georgia Metzgeroth et al.
ANNALS OF HEMATOLOGY (2009)
Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia: the ESCALATOR study
Ali Taher et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
Norbert Gattermann
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
分享论文
